Gene therapy in mouse models of huntington disease.
Gene therapy in mouse models of huntington disease.
复制标题
DOI:
10.1177/1073858410386236
复制
发表时间:
2011-04
期刊:
影响因子:
--
通讯作者:
Patterson PH
中科院分区:
文献类型:
--
作者:
Southwell AL;Patterson PH
Huntingtin, the protein that when mutated causes Huntington disease (HD), has many known interactors and participates in diverse cellular functions. Mutant Htt (mHtt) engages in a variety of aberrant interactions that lead to pathological gain of toxic functions as well as loss of normal functions. The broad symptomatology of HD, including diminished voluntary motor control, cognitive decline, and psychiatric disturbances, reflects the multifaceted neuropathology. Although currently available therapies for HD focus on symptom management, the autosomal dominant cause and the adult onset make this disease an ideal candidate for genetic intervention. A variety of gene therapy approaches have been tested in mouse models of HD, ranging from those aimed at ameliorating downstream pathology or replacing lost neuronal populations to more upstream strategies to reduce mHtt levels. Here the authors review the results of these preclinical trials.
登录
查看更多内容
影响因子:
3.8
作者:
Alberch, J;Pérez-Navarro, E;Canals, JM
通讯作者:
Canals, JM
DOI:
10.1111/j.1749-6632.2009.04975.x
发表时间:
2009-01-01
期刊:
OLIGONUCLEOTIDE THERAPEUTICS
影响因子:
--
作者:
Hu, Jiaxin;Matsui, Masayuki;Corey, David R.
通讯作者:
Corey, David R.
影响因子:
3.4
作者:
De Marchi, N;Daniele, F;Ragone, MA
通讯作者:
Ragone, MA
DOI:
10.1073/pnas.0501507102
发表时间:
2005-04-19
影响因子:
11.1
作者:
Harper, SQ;Staber, PD;Davidson, BL
通讯作者:
Davidson, BL
影响因子:
8.6
作者:
Biglan, Kevin M.;Ross, Christopher A.;Langbehn, Douglas R.;Aylward, Elizabeth H.;Stout, Julie C.;Queller, Sarah;Carlozzi, Noelle E.;Duff, Kevin;Beglinger, Leigh J.;Paulsen, Jane S.
通讯作者:
Paulsen, Jane S.